EUVIMEDOpdag EUVIMED
Crossref

Astragaloside IV attenuates high glucose‐induced NF‐κB ‐mediated inflammation through activation of PI3K / AKT‐ERK ‐dependent Nrf2/ ARE signaling pathway in glomerular mesangial cells

Xue Su, Hengjiang Guo, Yuying Zhou, Aili Cao, Qian Shen, Bingbing Zhu, Xingmei Yao, Yunman Wang, Hao Wang, Li Wang iD

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7875 ↗

At a glance

Journal article in Phytotherapy Research, 2023. Written by Xue Su and 9 co-authors. Institution: Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Major MEDLINE topics: NF-kappa B, Proto-Oncogene Proteins c-akt. Cited 30 times so far (Crossref); 38 references. Funded by: Clinical specialty of Shanghai Putuo District Health System, Innovation Program of Talent Project of Putuo District, National Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Inflammation is a key contributor to diabetic kidney disease pathogenesis, including reactive oxidation stress (ROS)‐mediated nuclear factor‐κB (NF‐κB) signaling pathway. In this study, we examined the effect of Astragaloside IV (AS‐IV) on anti‐inflammatory and anti‐oxidative properties under high glucose (HG) condition and the potential mechanism in glomerular mesangial cells (GMCs). We showed that AS‐IV concentration‐dependently reduced GMCs proliferation, restrained ROS release and hydrogen peroxide content, and suppressed pro‐inflammatory cytokines as well as pro‐fibrotic factors expression, which were associated with the inhibition of NF‐κB and nuclear factor‐erythroid 2‐related factor 2 (Nrf2) signaling activation. Accordingly, both NF‐κB overexpression by using RNA plasmid and Nrf2 gene silencing by using RNA interference weakened the ability of AS‐IV to ameliorate HG‐induced oxidative stress, inflammation, and cell proliferation. Furthermore, phosphatidylinositide 3‐kinases (PI3K)/serine/threonine protein kinase (Akt) and extracellular regulated protein kinases (ERK) signaling pathway regulated the process of AS‐IV‐induced Nrf2 activation and antioxidant capacity, which evidenced by using PI3K inhibitor LY294002 or ERK inhibitor PD98059 that largely abolished the AS‐IV efficacy. Taken together, these results indicated that AS‐IV protected against HG‐induced GMCs damage by inhibiting ROS/NF‐kB‐induced increases of inflammatory cytokines, fibrosis biomarkers, and cell proliferation via up‐regulation of Nrf2‐dependent antioxidant enzyme expression, which were mediated by PI3K/Akt and ERK signaling pathway activation.

Subjects

MeSH terms (MEDLINE)

NF-kappa BProto-Oncogene Proteins c-aktHumansPhosphatidylinositol 3-KinasesNF-E2-Related Factor 2AntioxidantsMesangial CellsReactive Oxygen SpeciesSignal TransductionPhosphatidylinositol 3-KinaseOxidative StressCytokinesGlucoseInflammationSaponinsTriterpenes

Author keywords

Astragaloside IVdiabetic kidney diseaseglomerular mesangial cellsinflammationoxidative stress

Substances

NF-kappa BProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesNF-E2-Related Factor 2AntioxidantsReactive Oxygen SpeciesPhosphatidylinositol 3-KinaseCytokinesGlucoseastragaloside A

Authors and institutions

  • Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Anesthesiology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, Hefei, China.
  • Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID profiles: Li Wang

Funding

  • Clinical specialty of Shanghai Putuo District Health System
  • Innovation Program of Talent Project of Putuo District
  • National Science Foundation of China
  • Science and Technology Innovation Project of Putuo District Health System
  • Shanghai Pujiang Program
  • National Natural Science Foundation of China

Cite

APA

Su, X., Guo, H., Zhou, Y., Cao, A., Shen, Q., Zhu, B., Yao, X., Wang, Y., Wang, H., & Wang, L. (2023). Astragaloside IV attenuates high glucose‐induced NF‐κB ‐mediated inflammation through activation of PI3K / AKT‐ERK ‐dependent Nrf2/ ARE signaling pathway in glomerular mesangial cells. Phytotherapy Research. https://doi.org/10.1002/ptr.7875

Vancouver

Su X, Guo H, Zhou Y, Cao A, Shen Q, Zhu B, et al. Astragaloside IV attenuates high glucose‐induced NF‐κB ‐mediated inflammation through activation of PI3K / AKT‐ERK ‐dependent Nrf2/ ARE signaling pathway in glomerular mesangial cells. Phytotherapy Research. 2023. doi:10.1002/ptr.7875

BibTeX
@article{Su2023,
  author = {Su, Xue and Guo, Hengjiang and Zhou, Yuying and Cao, Aili and Shen, Qian and Zhu, Bingbing and Yao, Xingmei and Wang, Yunman and Wang, Hao and Wang, Li},
  title = {Astragaloside IV attenuates high glucose‐induced NF‐κB ‐mediated inflammation through activation of PI3K / AKT‐ERK ‐dependent Nrf2/ ARE signaling pathway in glomerular mesangial cells},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7875}
}
Start for free →